Detalhe da pesquisa
1.
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.
N Engl J Med
; 389(7): 589-601, 2023 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272516
2.
Determining venous thromboembolism risk in patients with adult-type diffuse glioma.
Blood
; 141(11): 1322-1336, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399711
3.
Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients.
Cancer
; 130(9): 1577-1589, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38288941
4.
A systematic review of the impact of brain tumours on risk of motor vehicle crashes.
J Neurooncol
; 166(3): 395-405, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321326
5.
Caregiver survey in glioblastoma focused on cognitive dysfunction: development and results from a multicenter study.
Future Oncol
; 19(2): 173-188, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36974606
6.
Use of Trametinib in Children and Young Adults With Progressive Low-grade Glioma and Glioneuronal Tumors.
J Pediatr Hematol Oncol
; 45(4): e464-e470, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36730221
7.
Comparison of differing dose levels of methotrexate for patients with primary central nervous system lymphoma.
J Oncol Pharm Pract
; : 10781552231176754, 2023 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37198894
8.
Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial.
Support Care Cancer
; 30(4): 3463-3471, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35001215
9.
Caregiver burden by treatment and clinical characteristics of patients with glioblastoma.
Support Care Cancer
; 30(2): 1365-1375, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34510238
10.
Recurrent Glioblastoma Treated with Recombinant Poliovirus.
N Engl J Med
; 379(2): 150-161, 2018 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29943666
11.
Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group.
Support Care Cancer
; 29(6): 2821-2840, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231809
12.
Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series.
J Neurooncol
; 147(2): 477-483, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32140975
13.
Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide.
Support Care Cancer
; 28(5): 2229-2238, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31440823
14.
Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview.
Support Care Cancer
; 27(10): 3729-3737, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31363906
15.
Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.
Oncologist
; 23(2): 157-e21, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29133513
16.
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma.
Oncologist
; 23(8): 889-e98, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29666296
17.
Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas.
J Neurooncol
; 137(2): 349-356, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29264836
18.
Targeting BRAF-mutant glioma: reflections on the ROAR trial.
Lancet Oncol
; 23(1): 3-4, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838157
19.
Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study.
J Neurooncol
; 132(1): 55-62, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28074320
20.
Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data.
J Neurooncol
; 133(1): 27-35, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28470431